$INUV
Inuvo, Inc. Stock $inuv

$inuv Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000082932323000021 Filed on May 04, 2023

Income Statement

Concept	2023 Q2	2023 Q1
Revenue	$16.65M	$11.85M
YoY Change	-26.49%	-36.34%
Cost Of Revenue	$2.369M	$3.191M
YoY Change	-74.46%	-63.16%
Gross Profit	$14.28M	$8.657M
YoY Change	6.77%	-12.98%
Gross Profit Margin	85.78%	73.07%
Selling, General & Admin	$14.37M	$12.09M
YoY Change	-11.39%	0.32%
% of Gross Profit	100.6%	139.68%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$705.6K	$639.0K
YoY Change	89.19%	-7.35%
% of Gross Profit	4.94%	7.38%
Operating Expenses	$17.62M	$12.09M
YoY Change	8.67%	0.32%
Operating Profit	-$3.339M	-$3.435M
YoY Change	17.66%	63.13%
Interest Expense	-$38.19K	-$19.12K
YoY Change	-1343.97%	1812.0%
% of Operating Profit
Other Income/Expense, Net	$0.00	$14.42K
YoY Change	-100.0%	-18.55%
Pretax Income	-$3.377M	-$3.440M
YoY Change	4.56%	64.66%
Income Tax	$0.00
% Of Pretax Income
Net Earnings	-$3.377M	-$3.440M
YoY Change	4.56%	64.66%
Net Earnings / Revenue	-20.28%	-29.04%
Basic Earnings Per Share		-$0.03
Diluted Earnings Per Share	-$0.03	-$0.03
COMMON SHARES
Basic Shares Outstanding	121.6M shares	121.4M shares
Diluted Shares Outstanding	127.2M shares	121.0M shares

Balance Sheet

Concept	2023 Q2	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$5.045M	$1.970M
YoY Change	-40.07%	-76.04%
Cash & Equivalents	$5.000M	$2.000M
Short-Term Investments	$0.00	$0.00
Other Short-Term Assets	$828.6K	$970.4K
YoY Change	-22.88%	-57.01%
Inventory
Prepaid Expenses		$970.4K
Receivables	$10.80M	$9.121M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$16.67M	$12.06M
YoY Change	-26.2%	-41.25%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.680M	$1.687M
YoY Change	-0.48%	4.37%
Goodwill	$9.853M	$9.853M
YoY Change	0.0%	0.0%
Intangibles	$5.157M	$5.403M
YoY Change	-16.03%	-15.41%
Long-Term Investments	$0.00	$0.00
YoY Change	-100.0%	-100.0%
Other Assets	$685.2K	$66.92K
YoY Change	1818.17%	87.34%
Total Long-Term Assets	$17.62M	$18.09M
YoY Change	-11.45%	-11.42%
TOTAL ASSETS
Total Short-Term Assets	$16.67M	$12.06M
Total Long-Term Assets	$17.62M	$18.09M
Total Assets	$34.28M	$30.16M
YoY Change	-19.29%	-26.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$6.193M	$5.507M
YoY Change	-0.86%	21.92%
Accrued Expenses	$8.241M	$4.933M
YoY Change	18.38%	12.37%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$592.9K
YoY Change
Long-Term Debt Due	$74.10K	$86.28K
YoY Change	-29.28%	-18.7%
Total Short-Term Liabilities	$14.63M	$11.33M
YoY Change	7.02%	21.01%
LONG-TERM LIABILITIES
Long-Term Debt	$33.34K	$50.86K
YoY Change	-38.09%	-34.65%
Other Long-Term Liabilities	$3.555K	$7.253K
YoY Change	-76.2%	-49.02%
Total Long-Term Liabilities	$154.2K	$177.4K
YoY Change	-49.42%	-57.69%
TOTAL LIABILITIES
Total Short-Term Liabilities	$14.63M	$11.33M
Total Long-Term Liabilities	$154.2K	$177.4K
Total Liabilities	$14.78M	$11.51M
YoY Change	5.78%	17.63%
SHAREHOLDERS EQUITY
Retained Earnings	-$163.9M	-$160.5M
YoY Change	9.76%	9.93%
Common Stock	$137.8K	$121.6K
YoY Change	14.97%	1.53%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$19.50M	$18.65M
YoY Change
Total Liabilities & Shareholders Equity	$34.28M	$30.16M
YoY Change	-19.29%	-26.37%

Cashflow Statement

Concept	2023 Q2	2023 Q1
OPERATING ACTIVITIES
Net Income	-$3.377M	-$3.440M
YoY Change	4.56%	64.66%
Depreciation, Depletion And Amortization	$705.6K	$639.0K
YoY Change	89.19%	-7.35%
Cash From Operating Activities	$397.1K	-$3.231M
YoY Change	-60.75%	-9.77%
INVESTING ACTIVITIES
Capital Expenditures	$425.2K	$411.2K
YoY Change	-195.59%	-188.13%
Acquisitions
YoY Change
Other Investing Activities	-$10.00	$2.289M
YoY Change	-100.01%	-529.84%
Cash From Investing Activities	-$425.2K	$1.878M
YoY Change	19.26%	-287.93%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	3.104M	$391.5K
YoY Change	-12352.59%	-356.02%
NET CHANGE
Cash From Operating Activities	397.1K	-$3.231M
Cash From Investing Activities	-425.2K	$1.878M
Cash From Financing Activities	3.104M	$391.5K
Net Change In Cash	3.076M	-$961.8K
YoY Change	388.24%	-79.68%
FREE CASH FLOW
Cash From Operating Activities	$397.1K	-$3.231M
Capital Expenditures	$425.2K	$411.2K
Free Cash Flow	-$28.04K	-$3.642M
YoY Change	-101.93%	16.96%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000829323
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-32442
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	Inuvo, Inc.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-0450450
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	500 President Clinton Ave.,
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 300
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Little Rock
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	AR
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	72201
CY2023Q1	dei	City Area Code CityAreaCode	501
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	205-8508
CY2023Q1	dei	Security12b Title Security12bTitle	Common stock
CY2023Q1	dei	Trading Symbol TradingSymbol	INUV
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NYSEAMER
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	121641455	shares
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1969583	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2931415	usd
CY2023Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	0	usd
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	1529464	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1401803	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1440678	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	9120826	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	11119892	usd
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	970411	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	798977	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	12060820	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	16379748	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1687309	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1668972	usd
CY2023Q1	us-gaap	Goodwill Goodwill	9853342	usd
CY2022Q4	us-gaap	Goodwill Goodwill	9853342	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	5403166	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	5649291	usd
CY2023Q1	inuv	Referral Agreement ReferralAgreement	725000	usd
CY2022Q4	inuv	Referral Agreement ReferralAgreement	800000	usd
CY2023Q1	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	0	usd
CY2022Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	660126	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	220740	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	310162	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	138108	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	168750	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	66919	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	66919	usd
CY2023Q1	inuv	Other Assets Total Noncurrent OtherAssetsTotalNoncurrent	16407275	usd
CY2022Q4	inuv	Other Assets Total Noncurrent OtherAssetsTotalNoncurrent	17508590	usd
CY2023Q1	us-gaap	Assets Assets	30155404	usd
CY2022Q4	us-gaap	Assets Assets	35557310	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	5506837	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	8044802	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4932916	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5162458	usd
CY2023Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	592868	usd
CY2022Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	0	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	209658	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	287523	usd
CY2023Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	86276	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	101003	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	11328555	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	13595786	usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	107000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	107000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	12322	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	23878	usd
CY2023Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	50857	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	70597	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	7253	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	10733	usd
CY2023Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	177432	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	212208	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	121640362	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	121640362	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	120137124	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	120137124	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	121641	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	120138	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	179025439	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	178771604	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-84868	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-160497663	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-157057558	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	18649417	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	21749316	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	30155404	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	35557310	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	11847440	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	18609367	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3190563	usd
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	8661506	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	8656877	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	9947861	usd
CY2023Q1	inuv	Search Costs SearchCosts	7087550	usd
CY2022Q1	inuv	Search Costs SearchCosts	7169449	usd
CY2023Q1	us-gaap	Salaries And Wages SalariesAndWages	3422841	usd
CY2022Q1	us-gaap	Salaries And Wages SalariesAndWages	3157706	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1581889	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1726672	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	12092280	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	12053827	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-3435403	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2105966	usd
CY2023Q1	us-gaap	Financing Interest Expense FinancingInterestExpense	19120	usd
CY2022Q1	us-gaap	Financing Interest Expense FinancingInterestExpense	999	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	14418	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	17702	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-3440105	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2089263	usd
CY2022Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-98156	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3355237	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2187419	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	120970597	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	119282114	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	120970597	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	119282114	shares
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	639026	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	689712	usd
CY2023Q1	inuv	Finance And Operating Lease Right Of Use Asset Amortization FinanceAndOperatingLeaseRightOfUseAssetAmortization	30642	usd
CY2022Q1	inuv	Finance And Operating Lease Right Of Use Asset Amortization FinanceAndOperatingLeaseRightOfUseAssetAmortization	24259	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	432084	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	671158	usd
CY2023Q1	inuv	Grant Expense Derecognition Of Contingencies And Grants GrantExpenseDerecognitionOfContingenciesAndGrants	5000	usd
CY2022Q1	inuv	Grant Expense Derecognition Of Contingencies And Grants GrantExpenseDerecognitionOfContingenciesAndGrants	-10000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2083	usd
CY2022Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2500	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-38875	usd
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-81753	usd
CY2023Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	14418	usd
CY2022Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	17702	usd
CY2023Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-9874	usd
CY2022Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	12483	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2037941	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	702421	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-75000	usd
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-75000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	171434	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	849218	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-240104	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-977599	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-2537965	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-327918	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3230999	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3580762	usd
CY2023Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	411238	usd
CY2022Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	466634	usd
CY2023Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	0	usd
CY2022Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	1081080	usd
CY2023Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	2288876	usd
CY2022Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	548589	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1877638	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-999125	usd
CY2023Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	592868	usd
CY2022Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	34467	usd
CY2022Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	24407	usd
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	166872	usd
CY2022Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	128521	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	391529	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-152928	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-961832	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4732815	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2931415	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10475964	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1969583	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5743149	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	29953	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	7782	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	21749316	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-3440105	usd
CY2023Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	84868	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	432084	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2023Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	166872	usd
CY2023Q1	inuv	Adjustments To Additional Paid In Capital Change In Warrant Vesting AdjustmentsToAdditionalPaidInCapitalChangeInWarrantVesting	9874	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	18649417	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	32807995	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2089263	usd
CY2022Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-98156	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	671158	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2022Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	128520	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	12483	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	31175697	usd
CY2023Q1	inuv	Number Of Patents Issued NumberOfPatentsIssued	19	patent
CY2023Q1	inuv	Number Of Patents Pending NumberOfPatentsPending	8	patent
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2000000	usd
CY2023Q1	inuv	Working Capital Net WorkingCapitalNet	732000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-160500000	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of estimates</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The preparation of financial statements, in accordance with GAAP, requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, net revenues and expenses and disclosure of contingent assets and liabilities. The estimates and assumptions used in the accompanying consolidated financial statements are based upon management’s regular evaluation of the relevant facts and circumstances as of the date of the consolidated financial statements. We regularly evaluate estimates and assumptions related to capitalized labor, goodwill and purchased intangible asset valuations and income tax valuation allowance. Actual results may differ from the estimates and assumptions used in preparing the accompanying consolidated financial statements, and such differences could be material.</span></div>
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	11847440	usd
CY2023Q1	inuv	Percentage Of Total Revenue PercentageOfTotalRevenue	1
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	18609367	usd
CY2022Q1	inuv	Percentage Of Total Revenue PercentageOfTotalRevenue	1
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	16932635	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	16521397	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	15245326	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	14852425	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1687309	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1668972	usd
CY2023Q1	us-gaap	Depreciation Depreciation	392901	usd
CY2022Q1	us-gaap	Depreciation Depreciation	356793	usd
CY2023Q1	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	390000	usd
CY2023Q1	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	390000	usd
CY2023Q1	inuv	Finite Livedand Indefinite Lived Intangible Assets Long Term Portion Gross FiniteLivedandIndefiniteLivedIntangibleAssetsLongTermPortionGross	17565000	usd
CY2023Q1	inuv	Intangible Assets Accumulated Amortizationand Impairment Loss IntangibleAssetsAccumulatedAmortizationandImpairmentLoss	12161834	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	5403166	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	246125	usd
CY2023Q1	us-gaap	Goodwill Gross GoodwillGross	9853342	usd
CY2023Q1	us-gaap	Goodwill Goodwill	9853342	usd
CY2022Q4	us-gaap	Goodwill Goodwill	9853342	usd
CY2023Q1	inuv	Accrued Grant Current AccruedGrantCurrent	15000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	738375	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	769917	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	469500	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	469500	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	469500	usd
CY2023Q1	inuv	Finite Lived Intangible Assets Amortization Expense After Year Four FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour	2096374	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	5013166	usd
CY2022Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	390000	usd
CY2022Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	390000	usd
CY2022Q4	inuv	Finite Livedand Indefinite Lived Intangible Assets Long Term Portion Gross FiniteLivedandIndefiniteLivedIntangibleAssetsLongTermPortionGross	17565000	usd
CY2022Q4	inuv	Intangible Assets Accumulated Amortizationand Impairment Loss IntangibleAssetsAccumulatedAmortizationandImpairmentLoss	11915709	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	5649291	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1071294	usd
CY2022Q4	us-gaap	Goodwill Gross GoodwillGross	9853342	usd
CY2023Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	592868	usd
CY2023Q1	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	2840364	usd
CY2022Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	3321598	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1150815	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	782441	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	925428	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1044664	usd
CY2022Q4	inuv	Accrued Grant Current AccruedGrantCurrent	10000	usd
CY2023Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	1309	usd
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	3755	usd
CY2023Q1	inuv	Accrued Liabilities And Lease Liability Current AccruedLiabilitiesAndLeaseLiabilityCurrent	4932916	usd
CY2022Q4	inuv	Accrued Liabilities And Lease Liability Current AccruedLiabilitiesAndLeaseLiabilityCurrent	5162458	usd
CY2021Q3	inuv	Referral Agreement ReferralAgreement	1500000	usd
CY2021Q3	inuv	Referral Agreement Term ReferralAgreementTerm	P5Y
CY2023Q1	inuv	Amortization Of Referral Agreement As Marketing Expense AmortizationOfReferralAgreementAsMarketingExpense	475000	usd
CY2023Q1	inuv	Referral Agreement ReferralAgreement	725000	usd
CY2021Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	300000	shares
CY2021Q3	inuv	Class Of Warrant Or Right Vesting Period ClassOfWarrantOrRightVestingPeriod	P2Y
CY2023Q1	us-gaap	Sales Commissions And Fees SalesCommissionsAndFees	26000	usd
CY2022Q1	us-gaap	Sales Commissions And Fees SalesCommissionsAndFees	158000	usd
CY2023Q1	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	usd
CY2023Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	39109118	usd
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	37976018	usd
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	37976018	usd
CY2023Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	1240100	usd
CY2023Q1	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	107000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P3Y
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Period Increase Decrease ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease	150000	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Period Increase Decrease ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease	15000000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	24550000	shares
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	432084	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	671158	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	1881713	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	0	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	3130015	shares
CY2023Q1	inuv	Sharebased Compensation Arrangementby Sharebased Payment Award Numberof Shares Exercised SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofSharesExercised	6464123	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	14955862	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	24550000	shares
CY2023Q1	inuv	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeiture Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate	0
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	100000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.52
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	100000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0.52
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	0	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0
CY2021Q3	inuv	Class Of Warrant Or Right Granted In Period ClassOfWarrantOrRightGrantedInPeriod	300000	shares
CY2021Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.72
CY2021Q3	inuv	Class Of Warrant Or Right Number Of Tranches ClassOfWarrantOrRightNumberOfTranches	2	tranche
CY2021Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	149551	usd
CY2021Q3	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P7Y
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	85862	shares
CY2023Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-10000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	220740	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	138108	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	310162	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	168750	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	30642	usd
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	24259	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	85650	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0625
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	207955	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	16236	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	5251	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1590	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	231032	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	9052	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	221980	usd
CY2023Q1	inuv	Finance Lease Principal And Interest Payments On Liability FinanceLeasePrincipalAndInterestPaymentsOnLiability	37073	usd
CY2023Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P1Y9M18D
CY2023Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0625
CY2023Q1	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	68397	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	56180	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	18491	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	143068	usd
CY2023Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	5935	usd
CY2023Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	137133	usd

Files In Submission

Name	View Source	Status
inuv-20230331_pre.xml	Edgar Link	unprocessable
0000829323-23-000021-index-headers.html	Edgar Link	pending
0000829323-23-000021-index.html	Edgar Link	pending
0000829323-23-000021.txt	Edgar Link	pending
0000829323-23-000021-xbrl.zip	Edgar Link	pending
ex-311x1q23.htm	Edgar Link	pending
ex-312x1q23.htm	Edgar Link	pending
ex-321x1q23.htm	Edgar Link	pending
ex-322x1q23.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
inuv-20230331.htm	Edgar Link	pending
inuv-20230331.xsd	Edgar Link	pending
inuv-20230331_cal.xml	Edgar Link	unprocessable
inuv-20230331_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
inuv-20230331_g1.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
inuv-20230331_lab.xml	Edgar Link	unprocessable
inuv-20230331_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$INUV
Inuvo, Inc. Stock $inuv

2023 Q2 Form 10-Q Financial Statement

#000082932323000021 Filed on May 04, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$INUV Inuvo, Inc. Stock $inuv

2023 Q2 Form 10-Q Financial Statement

#000082932323000021 Filed on May 04, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$INUV
Inuvo, Inc. Stock $inuv